Literature DB >> 17361328

Study of the telomerase hTERT fraction, PCNA and CD34 expression on pituitary adenomas. Association with clinical and demographic characteristics.

Alma Ortiz-Plata1, Martha Lilia Tena Suck, Mario López-Gómez, Alfonso Heras, Aurora Sánchez García.   

Abstract

To determine the frequency of human telomerase reverse transcriptase (hTERT) catalytic fraction expression and its association with clinical and demographic characteristics of the patient, as well as with the expression of CD34 and proliferating cell nuclear antigen (PCNA) indexes on adenohypophyseal hormone tissues. A transverse study was realized with 49 cases of hypophyseal adenoma with analysis type cases and controls. The different adenohypophyseal hormones [prolactin (PRL), growth hormone (GH), follicle stimulating hormone, luteinizing hormone, thyroid gland stimulant hormone, adrenocorticotropic hormone (ACTH)], the catalytic fraction of the telomerase hTERT, the PCNA index and the CD34 density were determined by means of immunohistochemical techniques. The clinical, demographic and histopathological characteristics of the patients with and without hTERT expression were compared by means of Pearson's Chi-squared, Fisher's exact test and Mann-Whitney's U. Twenty-eight point six percent of the adenomas had positive expression for hTERT. The variables significantly correlated with hTERT's expression were younger age of presentation, diagnostic of adenoma producer, higher PCNA index, higher CD34 density, increased GH on serum and the expression on PRL tissue, GH and ACTH. Tobacco history had a negative association with hTERT's expression. The telomerase could be a marker of cellular proliferation associated with angiogenesis and hormonal activity. Evaluation of these variables could provide information about their biological behavior.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17361328     DOI: 10.1007/s11060-007-9365-8

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  50 in total

Review 1.  Hereditary factors in pancreatic cancer.

Authors:  Henry T Lynch; Randall E Brand; Jane F Lynch; Ramon M Fusaro; Scott E Kern
Journal:  J Hepatobiliary Pancreat Surg       Date:  2002

2.  [Pituitary adenomas: relationship between invasiveness and proliferative cell nuclear index].

Authors:  O I Tella Junior; M A Herculano; R Delcelo
Journal:  Arq Neuropsiquiatr       Date:  2000-12       Impact factor: 1.420

Review 3.  Diseases of the pituitary.

Authors:  S L Asa
Journal:  Neurosurg Clin N Am       Date:  1994-01       Impact factor: 2.509

4.  Effects of keratinocyte growth factor-2 (KGF-2) on wound healing in an ischaemia-impaired rabbit ear model and on scar formation.

Authors:  Y P Xia; Y Zhao; J Marcus; P A Jimenez; S M Ruben; P A Moore; F Khan; T A Mustoe
Journal:  J Pathol       Date:  1999-08       Impact factor: 7.996

Review 5.  Telomerase: regulation, function and transformation.

Authors:  Carolyn K Dong; Kenkichi Masutomi; William C Hahn
Journal:  Crit Rev Oncol Hematol       Date:  2005-05       Impact factor: 6.312

6.  The significant role of telomerase activity in human brain tumors.

Authors:  K Nakatani; N Yoshimi; H Mori; S Yoshimura; H Sakai; J Shinoda; N Sakai
Journal:  Cancer       Date:  1997-08-01       Impact factor: 6.860

Review 7.  Angiogenesis in pituitary adenomas.

Authors:  Shozo Yamada; Kouji Takada
Journal:  Microsc Res Tech       Date:  2003-02-01       Impact factor: 2.769

8.  Telomeres shorten during ageing of human fibroblasts.

Authors:  C B Harley; A B Futcher; C W Greider
Journal:  Nature       Date:  1990-05-31       Impact factor: 49.962

9.  Mecamylamine pretreatment counteracts cigarette smoke induced changes in hypothalamic catecholamine neuron systems and in anterior pituitary function.

Authors:  K Andersson
Journal:  Acta Physiol Scand       Date:  1985-11

10.  Relative expression of human telomerase catalytic subunit (hTERT) transcripts in astrocytic gliomas.

Authors:  V Kotoula; S Barbanis; E Nikolakaki; D Koufoyannis; C S Papadimitriou; G Karkavelas
Journal:  Acta Neuropathol       Date:  2004-02-20       Impact factor: 17.088

View more
  3 in total

Review 1.  Telomerase and the endocrine system.

Authors:  Furio Pacini; Silvia Cantara; Marco Capezzone; Stefania Marchisotta
Journal:  Nat Rev Endocrinol       Date:  2011-03-29       Impact factor: 43.330

2.  Telomere length and telomerase expression in pituitary tumors.

Authors:  C S Martins; B A Santana-Lemos; F P Saggioro; L Neder; H R Machado; A C Moreira; R T Calado; M de Castro
Journal:  J Endocrinol Invest       Date:  2015-05-08       Impact factor: 4.256

3.  Telomerase expression in clinically non-functioning pituitary adenomas.

Authors:  Liana Lumi Ogino; Elisa Baranski Lamback; Alexandro Guterres; Carlos Henrique de Azeredo Lima; Daniel Gomes Henriques; Monique Alvares Barbosa; Débora Aparecida Silva; Aline Helen da Silva Camacho; Leila Chimelli; Leandro Kasuki; Mônica R Gadelha
Journal:  Endocrine       Date:  2020-10-22       Impact factor: 3.633

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.